Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam toluenesulfonate vs midazolam in mechanically ventilated critically ill patients
ChiCTR2100046319Phase 4Recruiting
- Sponsor
- Fushun Mining Bureau General Hospital
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam and midazolam in None (2 arms), sponsored by Fushun Mining Bureau General Hospital. Primary endpoints: Dose required to achieve target RASS score, Onset time of the drug and 2 more. Started May 2021; status: recruiting.
02
Drugs
remimazolammidazolam
Beyond the preview
Go deeper on ChiCTR2100046319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046319.